Search

AstraZeneca PLC

Slēgts

SektorsVeselības aprūpe

11,732 -0.37

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

11716

Max

11776

Galvenie mērījumi

By Trading Economics

Ienākumi

-1.4B

2.5B

Pārdošana

96M

15B

P/E

Sektora vidējais

24.32

56.597

EPS

2.63

Dividenžu ienesīgums

1.96

Peļņas marža

16.095

Darbinieki

96,100

EBITDA

-510M

5.2B

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

1.96%

2.18%

Nākamie ieņēmumi

2026. g. 30. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-9.6B

252B

Iepriekšējā atvēršanas cena

11732.37

Iepriekšējā slēgšanas cena

11732

Ziņu noskaņojums

By Acuity

63%

37%

281 / 339 Rangs Healthcare

AstraZeneca PLC Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 12. sept. 12:41 UTC

News

Solana is trading higher as investor interest in cryptocurrency strengthens, aided by positive momentum from Ethereum and Pepeto's successful presale raising $10.96 million.

2026. g. 12. sept. 00:06 UTC

Macro News
Macro Event
News

Bitcoin trades higher, nearing $79,000, as the market rebounds from $388 million in liquidations amid inflation concerns and declining crude oil prices.

2026. g. 12. sept. 00:01 UTC

News

Kroger Co reported mixed second-quarter results, with shares lower in after-market trading. EPS guidance for the fiscal year is set between $5.10 and $5.30.

2026. g. 12. sept. 00:01 UTC

Social Media
News

Scholar Rock Holding Corp shares rose in after-market trading following FDA approval of ISEMBYLD for spinal muscular atrophy, with commercial supply set to begin shortly.

2026. g. 12. sept. 00:01 UTC

News

Nasdaq Inc announced a $100 million investment in Payward to develop blockchain-based equities, launching Nasdaq Equity Tokens in 2027. Shares traded higher in after-market hours.

2026. g. 12. sept. 00:01 UTC

News
Social Media

Johnson & Johnson shares rose in after-hours trading amid reports of Apollo Global Management discussing a $20 billion acquisition of its DePuy Synthes unit.

2026. g. 12. sept. 00:01 UTC

Social Media
News

Corning Inc shares fell in after-market trading following a $2 billion common stock offering announcement, raising investor concerns over potential dilution.

2026. g. 11. sept. 23:56 UTC

News

Ionis Pharmaceuticals received FDA approval for ZANVASTRO. Shares are higher in after-market trading, reflecting positive sentiment despite a setback in a partnered trial.

2026. g. 11. sept. 23:41 UTC

News
Social Media

Johnson & Johnson shares higher after news of Apollo Global Management's interest in acquiring its $20 billion orthopedics unit, DePuy Synthes.

2026. g. 11. sept. 23:26 UTC

News

Bentley Systems declared a quarterly dividend of $0.07 per share, scheduled for September 29, 2026, with shares trading higher in after-market hours.

2026. g. 11. sept. 23:16 UTC

News

Carriage Services Inc shares higher in after-hours trading, following a Friday close. Analysts set an average price target of $51.00, indicating potential upside.

2026. g. 11. sept. 23:06 UTC

Macro Event
News

Ethereum is higher in Friday's session, recovering after four days of declines. The asset remains above its 20-day moving average amid rising inflation pressures.

2026. g. 11. sept. 23:06 UTC

Macro Event
News

Ethereum is rising during Friday's session, supported by recent inflation data and fluctuating crude oil prices. The asset remains above its 20-day moving average.

2026. g. 11. sept. 23:01 UTC

Social Media
News

Oracle Corp's after-market shares declined following a $700 million expansion of its restructuring plan, raising total costs to $2.8 billion amid financial pressures.

2026. g. 11. sept. 23:01 UTC

News

Nasdaq Inc. shares rose in after-market trading following a $100 million investment in Payward to develop Nasdaq Equity Tokens, set to launch in 2027.

2026. g. 11. sept. 23:01 UTC

Social Media
News

Corning Inc shares fell in after-market trading following a $2 billion stock offering announcement, raising investor concerns about potential dilution.

2026. g. 11. sept. 22:51 UTC

News
Social Media

Scholar Rock Holding Corp gains after FDA approves ISEMBYLD for spinal muscular atrophy, with a U.S. launch set to begin shortly.

2026. g. 11. sept. 22:01 UTC

News

Estée Lauder Companies secured a legal win against Walmart over counterfeit products, but shares are trading lower in after-market hours amid ongoing retail sector concerns.

2026. g. 11. sept. 21:31 UTC

News

Warner Bros Discovery Inc. shares are higher in after-market hours following reports of Paramount's settlement talks with state attorneys general over its acquisition proposal.

2026. g. 11. sept. 20:51 UTC

News

Ralph Lauren Corp's Board declared a quarterly dividend of $1.00 per share, and shares are trading higher in after-market hours.

2026. g. 11. sept. 20:09 UTC

News

1-800-Flowers.Com Inc shares are lower after reporting Q2 revenue of $293.1 million and a non-GAAP loss of $0.80 per share.

2026. g. 11. sept. 20:09 UTC

News

Century Communities plans to open Grand Oaks of Callaway in Florida on September 26, featuring homes starting from the upper $200s. Shares are gaining.

2026. g. 11. sept. 20:09 UTC

News

Columbia Sportswear appoints Peter Rauch as President of Mountain Hardwear, effective September 28. Shares are higher today, despite pulling back from an earlier session high.

2026. g. 11. sept. 20:09 UTC

News

Clear Secure shares are lower after DA Davidson analyst Wyatt Swanson cut the price target to $45.00 from $55.00 while maintaining a Neutral rating.

2026. g. 11. sept. 20:09 UTC

News

Carvana Co's shares are lower today, continuing a downward trend amid institutional investment activity and persistent inflation pressures indicated by recent CPI data.

2026. g. 11. sept. 20:09 UTC

News

Ultragenyx Pharmaceutical shares are lower as Bronstein, Gewirtz & Grossman, LLC, initiates an investigation following disappointing Phase 3 study results for apazunersen.

2026. g. 11. sept. 20:09 UTC

News
Social Media
Correlated Moves

Snowflake Inc. shares are declining amid insider selling by director Benoit Dageville, who sold 50,000 shares at $335.72 on September 9.

2026. g. 11. sept. 20:09 UTC

News
Social Media

Advanced Micro Devices shares are higher today following positive growth projections for its server and data center businesses, potentially exceeding $65 billion by Q4 2026.

2026. g. 11. sept. 20:09 UTC

News

Intercontinental Exchange sponsors the 9/11 Day of Service initiative. Shares are advancing during Friday's trading, reflecting positive momentum since Thursday's close.

2026. g. 11. sept. 20:09 UTC

News
Social Media

Marvell Technology reports fiscal Q2 revenue of $2.73 billion, exceeding estimates. Shares are higher amid strong demand for AI networking and advanced technologies.

Salīdzinājums

Cenas izmaiņa

AstraZeneca PLC Prognoze

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

17 ratings

15

Pirkt

1

Turēt

1

Pārdot

Noskaņojums

By Acuity

281 / 339 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
help-icon Live chat